Literature DB >> 6437574

Scandinavian model for eliminating measles, mumps, and rubella.

E Rabo, J Taranger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6437574      PMCID： PMC1443676          DOI： 10.1136/bmj.289.6456.1402

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  15 in total

1.  [Vaccination against rubella].

Authors:  M Böttiger
Journal:  Lakartidningen       Date:  1979-10-10

2.  Current impact of measles in the United Kingdom.

Authors:  C L Miller
Journal:  Rev Infect Dis       Date:  1983 May-Jun

3.  The 'new' epidemiology of measles and rubella.

Authors:  J D Cherry
Journal:  Hosp Pract       Date:  1980-07

4.  The salutary effect of milk on amoebiasis and its reversal by iron.

Authors:  M J Murray; A Murray; C J Murray
Journal:  Br Med J       Date:  1980-06-07

5.  [Meningitis in mumps and orchitis in Stockholm during 1955-1976--an epidemiological background for a vaccination policy].

Authors:  B Bjorvatn; B Sköldenberg
Journal:  Lakartidningen       Date:  1978-06-07

6.  Rational strategy for rubella vaccination.

Authors:  A R Hinman; K J Bart; W A Orenstein; S R Preblud
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

7.  Rubella, measles and mumps antibodies following vaccination of children. A potential rubella problem.

Authors:  H H Balfour; D P Amren
Journal:  Am J Dis Child       Date:  1978-06

8.  An outbreak of rubella among hospital personnel.

Authors:  B F Polk; J A White; P C DeGirolami; J F Modlin
Journal:  N Engl J Med       Date:  1980-09-04       Impact factor: 91.245

9.  Strategy for rubella vaccination.

Authors:  E G Knox
Journal:  Int J Epidemiol       Date:  1980-03       Impact factor: 7.196

10.  Measles as a cause of fetal defects. A retrospective study of tem measles epidemics in Greenland.

Authors:  C S Jespersen; J Lttauer; U Sagild
Journal:  Acta Paediatr Scand       Date:  1977-05
View more
  16 in total

1.  Costs and benefits of a second measles inoculation of children in Israel, the West Bank, and Gaza.

Authors:  G M Ginsberg; T H Tulchinsky
Journal:  J Epidemiol Community Health       Date:  1990-12       Impact factor: 3.710

Review 2.  Rubella in Europe.

Authors:  A Galazka
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

3.  Prevention in family practice: Consensus statement from the front line.

Authors:  G Satenstein; J Lemelin; C Folkerson; K A Scott; W E Hogg
Journal:  Can Fam Physician       Date:  1991-10       Impact factor: 3.275

4.  Measles must go and with it rubella.

Authors:  J E Banatvala
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-04

5.  Measles and the government.

Authors:  T Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-18

6.  Seroepidemiology of measles in Catalonia (Spain) 1985-1986.

Authors:  L Salleras; J Vidal; J Canela; M T Jimenez De Anta; T Pumarola; J J Coll; M L De La Puente; L Serra
Journal:  Eur J Epidemiol       Date:  1990-06       Impact factor: 8.082

7.  Measles, mumps, and rubella: the need for a change in immunisation policy.

Authors:  D Walker; H Carter; I G Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-07

8.  Surveillance of antibody to measles, mumps, and rubella by age.

Authors:  P Morgan-Capner; J Wright; C L Miller; E Miller
Journal:  BMJ       Date:  1988-09-24

Review 9.  Measles control in developing and developed countries: the case for a two-dose policy.

Authors:  T H Tulchinsky; G M Ginsberg; Y Abed; M T Angeles; C Akukwe; J Bonn
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

10.  Duration of the immune response to MMR vaccine in children of two age-different groups.

Authors:  S Li Volti; G Giammanco-Bilancia; M Grassi; R Garozzo; R Gluck; G Giammanco
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.